In Vitro Gametogenesis and the Fragility of Incidental Protections for Egg Donors

As the Technological Shadow Shifts: In Vitro Gametogenesis and the Fragility of Incidental Protections for Egg Donors- Emily Packard Dawson, PhD In 2025, researchers created, for the first time, human lab-derived eggs capable of fertilization using a technique that still requires donated eggs — not for their DNA, but for their cytoplasmic environment. This reliance matters because egg donation has long raised concerns about financial inducement, exploitation, and donor welfare. If ever pursued clinically, this approach to in vitro gametogenesis (IVG) – the creation of eggs and sperm in the laboratory – would decouple genetic contribution from egg donation, likely reshaping who donates and under what conditions. This talk will argue that the current egg donor market contains incidental protections — structural advantages that buffer some donors from harm, not by design, but because of how eggs are currently valued. It will also introduce the concept of the "technological shadow" to examine how scientific constraints can create temporary protections that disappear as technology advances, and why governance must be built before the shadow shifts.